General Archive

-
News releasesHer Majesty Queen Elizabeth II
We at LifeArc are deeply saddened by the passing of Her Majesty Queen Elizabeth II.
-
News releasesLifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million
First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its science
-
ArticlesSeven questions about LifeArc’s 2030 ambitions
Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.
-
News releasesLifeArc helps create new MRC spin-out company
The new company aims to re-programme microbes to enable new materials to be produced – such as drugs and biodegradable…
-
News releasesDriving translational research into childhood rare diseases
Four grants awarded to projects that aim to translate research discoveries into benefits for children affected by rare diseases
-
ArticlesAdvancing novel gene therapies into the clinic
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
-
ArticlesStudy reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
-
ArticlesStartup wins first Advise & Connect Innovation Award
iLOF is a startup that has a novel technology with the potential to transform personalised medicine.
-
ArticlesMilner Therapeutics Institute and LifeArc extend strategic partnership
Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics
-
News releasesNew £4.25 million grant kick starts UK-wide collaborative research effort to end motor neuron disease
Collaboration will work together to find solutions to MND within years, not decades
-
News releasesNew £30 million translational partnership will accelerate development of new treatments for people with dementia
Funding will accelerate development of new diagnostic tests, treatments, and devices for people with dementia.
-
News releasesPromising new asthma medicine ready to enter early clinical trials
LifeArc scientists instrumental to the development of the world’s first anti-IL17BR antibody, now being trialled as a treatment for severe…
